🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

32+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 12 of 32 recruiting trials for “chronic-beryllium-disease”

Phase 2RecruitingNCT06300320 ↗

A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease

🏥 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.📍 12 sites📅 Started May 2024View details ↗
Phase 1RecruitingNCT06325709 ↗

Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous Disease

👨‍⚕️ Suk S De Ravin, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Apr 2024View details ↗
Phase 2RecruitingNCT06046248 ↗

Belumosudil and Rituximab for Primary Treatment of Chronic Graft-Versus-Host-Disease

👨‍⚕️ Scott Solomon, MD, BMTGA/Northside Hospital📍 1 site📅 Started Jan 2024View details ↗
Phase 2RecruitingNCT05996627 ↗

Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease

👨‍⚕️ Stephanie Lee, MD, MPH, Fred Hutch/University of Washington Cancer Consortium📍 4 sites📅 Started Dec 2023View details ↗
Phase 1, PHASE2Enrolling by InvitationNCT05104723 ↗

Safety and Efficacy of Tofacitinib for Chronic Granulomatous Disease With Inflammatory Complications

👨‍⚕️ Christa S Zerbe, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Aug 2022View details ↗
Phase 1, PHASE2RecruitingNCT05333471 ↗

Fecal Microbiota Transplantation for Chronic Granulomatous Disease-Associated Colitis

👨‍⚕️ Suchitra K Hourigan, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Aug 2022View details ↗
Phase 1RecruitingNCT05189925 ↗

NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)

👨‍⚕️ Suk S De Ravin, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Jul 2022View details ↗
Phase 1, PHASE2RecruitingNCT05463133 ↗

Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists

👨‍⚕️ Elizabeth M Kang, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Jul 2022View details ↗
Phase 2RecruitingNCT02918188 ↗

Therapeutic Effects of Hydrogen on Steroid-refractory/or Steroid-dependent cGVHD

👨‍⚕️ Liren Qian, M.D., Navy General Hospital, Beijing📍 1 site📅 Started Jan 2016View details ↗
Phase 2RecruitingNCT03055247 ↗

Combination of Ibuprofen, G-CSF and Plerixafor as Stem Cells Mobilization Regimen in Patients Affected by X-CGD

👨‍⚕️ Fabio Ciceri, MD, PhD, Ospedale San Raffaele📍 2 sites📅 Started Nov 2015View details ↗
RecruitingNCT00128973 ↗

Evaluation of Patients With Immune Function Abnormalities

👨‍⚕️ Harry L Malech, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Sep 2005View details ↗
NARecruitingNCT00001405 ↗

Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and Granulocytes

👨‍⚕️ Harry L Malech, M.D., National Institute of Allergy and Infectious Diseases (NIAID)📍 1 site📅 Started Feb 1994View details ↗
← PreviousPage 2 of 2

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →